Endgame for MicroGeneSys vaccine trial?
D016915:AIDS Vaccines / Q000191:economics / Q000627:therapeutic use*; D000163:Acquired Immunodeficiency Syndrome / Q000628:therapy; D002986:Clinical Trials as Topic; D006077:Government Agencies; D006801:Humans; D009316:National Institutes of Health (U.S.); D011994:Recombinant Proteins / Q000191:economics / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration; D014614:Vaccines, Synthetic / Q000191:economics / Q000627:therapeutic use
D016915:AIDS Vaccines; D011994:Recombinant Proteins; D014614:Vaccines, Synthetic; C053473:VaxSyn HIV-1 (gp160) vaccine